-
2
-
-
0030248255
-
-
Velden van der J, Lindert van ACM, Gimbrere CHF et al. Epidemiologic data on vulvar cancer: Comparison of hospital with population-based data. Gynecol Oncol 1996; 62: 379-383.
-
Velden van der J, Lindert van ACM, Gimbrere CHF et al. Epidemiologic data on vulvar cancer: Comparison of hospital with population-based data. Gynecol Oncol 1996; 62: 379-383.
-
-
-
-
3
-
-
0031669854
-
Preoperative chemoradiation for advanced vulvar cancer: A phase II study of the gynaecologic oncology group
-
Moore DH, Thomas GM, Montana GS et al. Preoperative chemoradiation for advanced vulvar cancer: A phase II study of the gynaecologic oncology group. Int J Radiat Oncol Biol Phys 1998; 42: 79-85.
-
(1998)
Int J Radiat Oncol Biol Phys
, vol.42
, pp. 79-85
-
-
Moore, D.H.1
Thomas, G.M.2
Montana, G.S.3
-
4
-
-
0029976236
-
Combined preoperative chemoradiotherapy followed by radical surgery in locally advanced vulvar carcinoma
-
Lupi G, Raspaliesi F, Zucali R et al. Combined preoperative chemoradiotherapy followed by radical surgery in locally advanced vulvar carcinoma. Cancer 1996; 77: 1472-1478.
-
(1996)
Cancer
, vol.77
, pp. 1472-1478
-
-
Lupi, G.1
Raspaliesi, F.2
Zucali, R.3
-
6
-
-
0028806282
-
Staging and recurrence of disease in squamous cell carcinoma of the vulva
-
Ndubisi B, Kaminski PF, Olt G et al. Staging and recurrence of disease in squamous cell carcinoma of the vulva. Gynecol Oncol 1995; 59: 34-37.
-
(1995)
Gynecol Oncol
, vol.59
, pp. 34-37
-
-
Ndubisi, B.1
Kaminski, P.F.2
Olt, G.3
-
7
-
-
0025358118
-
Bleomycin, methotrexate and CCNU in advanced inoperable squamous cell carcinoma of the vulva. A phase II study of the EORTC gynaecological cancer cooperative group (GCCG)
-
Durrant KR, Mangioni C, Lacave AJ et al. Bleomycin, methotrexate and CCNU in advanced inoperable squamous cell carcinoma of the vulva. A phase II study of the EORTC gynaecological cancer cooperative group (GCCG). Gynecol Oncol 1990; 37: 359-362.
-
(1990)
Gynecol Oncol
, vol.37
, pp. 359-362
-
-
Durrant, K.R.1
Mangioni, C.2
Lacave, A.J.3
-
8
-
-
0027181564
-
Cisplatin (P), bleomycin(B), and methotrexate (M) preoperative chemotherapy in locally advanced vulvar carcinoma
-
Benedetti-Panici P, Greggi S, Scambia G et al. Cisplatin (P), bleomycin(B), and methotrexate (M) preoperative chemotherapy in locally advanced vulvar carcinoma. Gynecol Oncol 1992; 50: 49-53.
-
(1992)
Gynecol Oncol
, vol.50
, pp. 49-53
-
-
Benedetti-Panici, P.1
Greggi, S.2
Scambia, G.3
-
9
-
-
29144521739
-
Neoadjuvant chemotherapy in vulvar cancer: Avoiding primary exenteration
-
Geisler JP, Manahan KJ, Buller RE. Neoadjuvant chemotherapy in vulvar cancer: Avoiding primary exenteration. Gynecol Oncol 2006; 100: 53-57.
-
(2006)
Gynecol Oncol
, vol.100
, pp. 53-57
-
-
Geisler, J.P.1
Manahan, K.J.2
Buller, R.E.3
-
10
-
-
0034989545
-
Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable squamous-cell carcinoma of the vulva: An EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer
-
Wagenaar HC, Colombo N, Vergote I et al. Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable squamous-cell carcinoma of the vulva: An EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer. Gynecol Oncol 2001; 81: 348.
-
(2001)
Gynecol Oncol
, vol.81
, pp. 348
-
-
Wagenaar, H.C.1
Colombo, N.2
Vergote, I.3
-
11
-
-
0019174457
-
Bleomycin alone or combined with mitomycin C in treatment of advanced or recurrent squamous cell carcinoma of the vulva
-
Trope C, Johnsson JE, Larsson G, Simonson E. Bleomycin alone or combined with mitomycin C in treatment of advanced or recurrent squamous cell carcinoma of the vulva. Cancer Treat Rep 1980; 64: 639-642.
-
(1980)
Cancer Treat Rep
, vol.64
, pp. 639-642
-
-
Trope, C.1
Johnsson, J.E.2
Larsson, G.3
Simonson, E.4
-
12
-
-
0022611538
-
Phase II trials of cisplatin and pierazinedione in advanced or recurrent squamous cell carcinoma of the vulva: A Gynecologic Oncology Group Study
-
Thigpen JT, Blesing JA, Homesley HD, Lewis GD. Phase II trials of cisplatin and pierazinedione in advanced or recurrent squamous cell carcinoma of the vulva: A Gynecologic Oncology Group Study. Gynecol Oncol 1986; 23: 358-363.
-
(1986)
Gynecol Oncol
, vol.23
, pp. 358-363
-
-
Thigpen, J.T.1
Blesing, J.A.2
Homesley, H.D.3
Lewis, G.D.4
-
13
-
-
0024588405
-
Mitoxantrone in the treatment of advanced vulvar and vaginal carcinoma. A Gynecologic Oncology Group study
-
Muss HB, Bundy BN, Christopherson WA. Mitoxantrone in the treatment of advanced vulvar and vaginal carcinoma. A Gynecologic Oncology Group study. Am J Clin Oncol 1989; 12: 142-144.
-
(1989)
Am J Clin Oncol
, vol.12
, pp. 142-144
-
-
Muss, H.B.1
Bundy, B.N.2
Christopherson, W.A.3
-
14
-
-
0018750835
-
Chemotherapy of squamous cell carcinoma of the vulva: A review
-
Deppe G, Cohen CJ, Bruckner HW. Chemotherapy of squamous cell carcinoma of the vulva: A review. Gynecol Oncol 1979; 7: 345-348.
-
(1979)
Gynecol Oncol
, vol.7
, pp. 345-348
-
-
Deppe, G.1
Cohen, C.J.2
Bruckner, H.W.3
-
15
-
-
17844410931
-
Taxanes in treatment of head and neck cancer
-
Schrijvers D, Vermorken JB. Taxanes in treatment of head and neck cancer. Curr Opin Oncol 2005; 17: 218-224.
-
(2005)
Curr Opin Oncol
, vol.17
, pp. 218-224
-
-
Schrijvers, D.1
Vermorken, J.B.2
-
16
-
-
0029865737
-
Paclitaxel has moderate activity in squamous cervix cancer: A Gynecological Oncology Group study
-
McGuire WP, Blessing JA, Moore D et al. Paclitaxel has moderate activity in squamous cervix cancer: A Gynecological Oncology Group study. J Clin Oncol 1996; 14: 792-795.
-
(1996)
J Clin Oncol
, vol.14
, pp. 792-795
-
-
McGuire, W.P.1
Blessing, J.A.2
Moore, D.3
-
17
-
-
4143135504
-
Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent or persistent squamous cell carcinoma of the cervix: A Gynecological Oncology Group study
-
Moore DH, Blessing JA, McQuellon RP et al. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent or persistent squamous cell carcinoma of the cervix: A Gynecological Oncology Group study. J Clin Oncol 2004; 22: 3113-3119.
-
(2004)
J Clin Oncol
, vol.22
, pp. 3113-3119
-
-
Moore, D.H.1
Blessing, J.A.2
McQuellon, R.P.3
-
18
-
-
0019365237
-
Reporting results of cancer treatment
-
Miller AB, Hoogstraaten B et al. Reporting results of cancer treatment. Cancer 1981; 47: 207-214.
-
(1981)
Cancer
, vol.47
, pp. 207-214
-
-
Miller, A.B.1
Hoogstraaten, B.2
-
19
-
-
69849104613
-
-
NCI-CTC Toxicity Grading (version 1.0). National Cancer Institute. Guidelines for the Reporting of Adverse Drugs Reactions. Bethesda, MD: Division of Cancer Treatment 1988.
-
NCI-CTC Toxicity Grading (version 1.0). National Cancer Institute. Guidelines for the Reporting of Adverse Drugs Reactions. Bethesda, MD: Division of Cancer Treatment 1988.
-
-
-
-
20
-
-
0024536437
-
Optimal two-stage designs for phase II clinical trials
-
Simon R. Optimal two-stage designs for phase II clinical trials. Control Clin Trials 1958; 10: 1-10.
-
(1958)
Control Clin Trials
, vol.10
, pp. 1-10
-
-
Simon, R.1
-
21
-
-
33845382806
-
Nonparametric estimation from incomplete observations
-
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
-
(1958)
J Am Stat Assoc
, vol.53
, pp. 457-481
-
-
Kaplan, E.L.1
Meier, P.2
-
22
-
-
0025247973
-
Effective chemotherapy consisting of bleomycin, vincristine, mitomycine C, and cisplatin (BOMP) for a patient with inoperable vulvar cancer
-
Shimizi Y, Hasumi K, Masubuchi K. Effective chemotherapy consisting of bleomycin, vincristine, mitomycine C, and cisplatin (BOMP) for a patient with inoperable vulvar cancer. Gynecol Oncol 1990: 423-427.
-
(1990)
Gynecol Oncol
, pp. 423-427
-
-
Shimizi, Y.1
Hasumi, K.2
Masubuchi, K.3
-
23
-
-
0029865737
-
Paclitaxel has moderate activity in squamous cervix cancer: A Gynecological Oncology Group study
-
McGuire WP, Blessing JA, Moore D et al. Paclitaxel has moderate activity in squamous cervix cancer: A Gynecological Oncology Group study. J Clin Oncol 1996; 14: 792-795.
-
(1996)
J Clin Oncol
, vol.14
, pp. 792-795
-
-
McGuire, W.P.1
Blessing, J.A.2
Moore, D.3
-
24
-
-
9844223395
-
An update of a phase II study of paclitaxel in advanced or recurrent squamous cell cancer of the cervix
-
Kadelka AP, Winn R, Edwards CL et al. An update of a phase II study of paclitaxel in advanced or recurrent squamous cell cancer of the cervix. Anticancer Drugs 1997; 8: 657-661.
-
(1997)
Anticancer Drugs
, vol.8
, pp. 657-661
-
-
Kadelka, A.P.1
Winn, R.2
Edwards, C.L.3
-
25
-
-
33847284541
-
Pharmacogenetics of paclitaxel metabolism
-
Spratlin J, Sawyer MB. Pharmacogenetics of paclitaxel metabolism. Crit Rev Oncol Hematol 2007; 61: 222-229.
-
(2007)
Crit Rev Oncol Hematol
, vol.61
, pp. 222-229
-
-
Spratlin, J.1
Sawyer, M.B.2
-
26
-
-
17744372477
-
Phase II trial of paclitaxel-carboplatin combination in recurrent squamous cell carcinoma of the head and neck
-
Pivot X, Cals L, Cupissol D et al. Phase II trial of paclitaxel-carboplatin combination in recurrent squamous cell carcinoma of the head and neck. Oncology 2001; 60: 66-71.
-
(2001)
Oncology
, vol.60
, pp. 66-71
-
-
Pivot, X.1
Cals, L.2
Cupissol, D.3
-
27
-
-
4143135504
-
Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: A Gynaecological Oncology Group Study
-
Moore DH, Blessing JA, McQuellon RP et al. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: A Gynaecological Oncology Group Study. J Clin Oncol 2004; 22: 3113-3119.
-
(2004)
J Clin Oncol
, vol.22
, pp. 3113-3119
-
-
Moore, D.H.1
Blessing, J.A.2
McQuellon, R.P.3
-
28
-
-
34247156192
-
A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical caner
-
Moore KN, Herzog TJ, Lewin S et al. A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical caner. Gynecol Oncol 2007; 105: 299-303.
-
(2007)
Gynecol Oncol
, vol.105
, pp. 299-303
-
-
Moore, K.N.1
Herzog, T.J.2
Lewin, S.3
|